Correction: The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma

نویسندگان

  • Soo Fan Ang
  • Elizabeth Shu-Hui Ng
  • Huihua Li
  • Yu-Han Ong
  • Su Pin Choo
  • Joanne Ngeow
  • Han Chong Toh
  • Kiat Hon Lim
  • Hao Yun Yap
  • Chee Kiat Tan
  • London Lucien Peng Jin Ooi
  • Peng Chung Cheow
  • Alexander Yaw Fui Chung
  • Pierce Kah Hoe Chow
  • Kian Fong Foo
  • Min-Han Tan
چکیده

There is an error in the order of authors. The correct order is: Soo Fan Ang , Elizabeth ShuHui Ng, Huihua Li, Yu-Han Ong, Su Pin Choo, Joanne Ngeow, Han Chong Toh, Kiat Hon Lim, Hao Yun Yap, Chee Kiat Tan, London Lucien Peng Jin Ooi, Peng Chung Cheow, Alexander Yaw Fui Chung, Pierce Kah Hoe Chow, Kian Fong Foo, Min-Han Tan 1 Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Republic of Singapore, 2Health Services Research, Singapore General Hospital, Singapore, Republic of Singapore, 3 Centre for Quantitative Medicine, Duke-National University of Singapore Graduate Medical School, Singapore, Republic of Singapore, 4 Department of Pathology, Singapore General Hospital, Singapore, Republic of Singapore, 5 Department of General Surgery, Singapore General Hospital, Singapore, Republic of Singapore, 6 Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore, Republic of Singapore, 7 Department of Hepatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Republic of Singapore, 8 Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, Republic of Singapore, 9Office of Clinical Sciences, Duke-National University of Singapore Graduate Medical School, Singapore, Republic of Singapore.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma

BACKGROUND AND AIMS Surgery is the primary curative option in patients with hepatocellular carcinoma (HCC). Current prognostic models for HCC are developed on datasets of primarily patients with advanced cancer, and may be less relevant to resectable HCC. We developed a postoperative nomogram, the Singapore Liver Cancer Recurrence (SLICER) Score, to predict outcomes of HCC patients who have und...

متن کامل

Comparing PET metabolic parameters with clinicopathological factors in predicting onset of early recurrence in recently diagnosed hepatocellular carcinoma

Introduction: Early recurrence of hepatocellular carcinoma (HCC) is a major risk factor affecting survival even after hepatectomy. Many clinical, biochemical parameters and pathological grading like fibrosis 1 index have been used for risk stratifying HCC. However not many studies have combined all of them. It is therefore important to risk stratify HCC especially with newer PE...

متن کامل

Prognostic molecular markers in hepatocellular carcinoma (Review article

Hepatocellular carcinoma (HCC) is the 5th commonest malignancy worldwide and is the third most common cause of cancer-related death. The prevalence is different in the world. The ability to predict patients at higher risk of recurrence and with a poor prognosis would help to guide surgical and chemotherapeutic treatment according to individual risk. As understanding of hepatocarcinogenesi...

متن کامل

Evaluation of Silibinin effects on the Viability of HepG2 (Human hepatocellular liver carcinoma) and HUVEC (Human Umbilical Vein Endothelial) cell lines

Human hepatocellular carcinoma is one of the most common recurrent malignancies, for as much as, there is no effective therapy. Silibinin, a widely used drug and supplement for various liver disorders, demonstrated anticancer effects against human hepatocellular carcinoma, human prostate adenocarcinoma cells, human breast carcinoma cells, human ectocervical carcinoma cells, and human colon canc...

متن کامل

Evaluation of Silibinin effects on the Viability of HepG2 (Human hepatocellular liver carcinoma) and HUVEC (Human Umbilical Vein Endothelial) cell lines

Human hepatocellular carcinoma is one of the most common recurrent malignancies, for as much as, there is no effective therapy. Silibinin, a widely used drug and supplement for various liver disorders, demonstrated anticancer effects against human hepatocellular carcinoma, human prostate adenocarcinoma cells, human breast carcinoma cells, human ectocervical carcinoma cells, and human colon canc...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 10  شماره 

صفحات  -

تاریخ انتشار 2015